| ASSET | YEAR | % RETURN |
|---|---|---|
Cato (CATO) | 1991 | 1,834.15% |
Envela (ELA) | 1991 | 985.47% |
BioLife Solutions (BLFS) | 1991 | 765.98% |
Biomerica (BMRA) | 1991 | 652.87% |
Magna International (MGA) | 1991 | 610.52% |
Shyft (SHYF) | 1991 | 593.83% |
Jack Henry & Associates (JKHY) | 1991 | 573.24% |
International Game Technology (IGT) | 1991 | 441.2% |
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
Oppenheimer (OPY) | 1991 | 418.2% |
Gencor Industries (GENC) | 1991 | 411.21% |
Vicor (VICR) | 1991 | 398.56% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
CEL-SCI (CVM) | 1991 | 379.07% |
Mesa Laboratories (MLAB) | 1991 | 361.54% |
National HealthCare (NHC) | 1991 | 335.89% |
Veru (VERU) | 1991 | 325.4% |
Toll Brothers (TOL) | 1991 | 309.1% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Bio-Techne (TECH) | 1991 | 303.96% |
Electronic Arts (EA) | 1991 | 302.6% |
Educational Development (EDUC) | 1991 | 299.7% |
Charles Schwab (SCHW) | 1991 | 295.22% |
Plexus (PLXS) | 1991 | 289.75% |
Celldex Therapeutics (CLDX) | 1991 | 282.61% |
